← Back to Search

Plant-Based Meals for Multiple Myeloma

N/A

Recruiting

Led By Kate Markey

Research Sponsored by Fred Hutchinson Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Planned first autologous stem cell transplantation for multiple myeloma

At least 18 years of age

Must not have

Planned inpatient transplantation

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 1 year

Awards & highlights

No Placebo-Only Group

Summary

"This trial examines how a plant-based meal delivery service can affect the gut bacteria in patients with multiple myeloma undergoing a specific type of stem cell transplant. The study aims to see if the service can

Who is the study for?

This trial is for patients with multiple myeloma who are undergoing an autologous hematopoietic cell transplant. The study aims to see if a plant-based whole-foods meal delivery can improve their gut microbiome, which is important for health during the transplant process.

What is being tested?

The intervention being tested is a plant-based whole-foods meal delivery service designed to enhance microbial diversity in the gut. This will be evaluated through medical chart reviews, biospecimen collection to analyze microbiome changes, and questionnaires about dietary intake.

What are the potential side effects?

Since this trial involves dietary intervention rather than medication or invasive procedures, side effects may include changes in digestion or food preferences but are generally expected to be minimal.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am scheduled for my first stem cell transplant for multiple myeloma.

Select...

I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am scheduled for an inpatient transplant procedure.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Collection rate

Enrollment rate

Tolerability of the delivered diet: Patient opinion

+1 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Supportive care (meal delivery service)Experimental Treatment4 Interventions

Patients receive 3 meals per day and snacks delivered twice weekly and meet with dietitian once weekly on days -7 to 28. Patients undergo blood and stool sample collection on study.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Biospecimen Collection

2004

Completed Phase 3

~2030

0 / 3Eligibility criteria met